全文获取类型
| 收费全文 | 10958篇 |
| 免费 | 643篇 |
| 国内免费 | 40篇 |
专业分类
| 耳鼻咽喉 | 173篇 |
| 儿科学 | 361篇 |
| 妇产科学 | 276篇 |
| 基础医学 | 1443篇 |
| 口腔科学 | 239篇 |
| 临床医学 | 830篇 |
| 内科学 | 2685篇 |
| 皮肤病学 | 463篇 |
| 神经病学 | 859篇 |
| 特种医学 | 372篇 |
| 外科学 | 1559篇 |
| 综合类 | 42篇 |
| 一般理论 | 2篇 |
| 预防医学 | 903篇 |
| 眼科学 | 154篇 |
| 药学 | 566篇 |
| 中国医学 | 49篇 |
| 肿瘤学 | 665篇 |
出版年
| 2023年 | 61篇 |
| 2022年 | 153篇 |
| 2021年 | 358篇 |
| 2020年 | 136篇 |
| 2019年 | 316篇 |
| 2018年 | 399篇 |
| 2017年 | 209篇 |
| 2016年 | 205篇 |
| 2015年 | 247篇 |
| 2014年 | 407篇 |
| 2013年 | 490篇 |
| 2012年 | 548篇 |
| 2011年 | 626篇 |
| 2010年 | 356篇 |
| 2009年 | 389篇 |
| 2008年 | 500篇 |
| 2007年 | 530篇 |
| 2006年 | 506篇 |
| 2005年 | 524篇 |
| 2004年 | 561篇 |
| 2003年 | 540篇 |
| 2002年 | 497篇 |
| 2001年 | 361篇 |
| 2000年 | 410篇 |
| 1999年 | 316篇 |
| 1998年 | 90篇 |
| 1997年 | 71篇 |
| 1996年 | 82篇 |
| 1995年 | 61篇 |
| 1994年 | 53篇 |
| 1993年 | 51篇 |
| 1992年 | 179篇 |
| 1991年 | 142篇 |
| 1990年 | 147篇 |
| 1989年 | 129篇 |
| 1988年 | 129篇 |
| 1987年 | 109篇 |
| 1986年 | 95篇 |
| 1985年 | 87篇 |
| 1984年 | 66篇 |
| 1983年 | 41篇 |
| 1979年 | 50篇 |
| 1978年 | 25篇 |
| 1977年 | 24篇 |
| 1976年 | 28篇 |
| 1975年 | 37篇 |
| 1974年 | 44篇 |
| 1973年 | 24篇 |
| 1972年 | 31篇 |
| 1969年 | 26篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
María del Carmen Azorín Samper Marta Hernandorena Gonzlez Alberto Ibez Arias Sandra Díaz Sierra Marta Bertolo Domínguez Flix Checa Ayet 《The breast journal》2020,26(2):252-254
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment. 相似文献
2.
A case of Rubinstein‐Taybi syndrome associated with growth hormone deficiency in childhood 
下载免费PDF全文
下载免费PDF全文 3.
4.
5.
6.
7.
8.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
9.
Selcen Yuksel Selim Ayhan Vugar Nabiyev Montse Domingo-Sabat Alba Vila-Casademunt Ibrahim Obeid Francisco Sanchez Perez-Grueso Emre Acaroglu 《The spine journal》2019,19(1):71-78
BACKGROUND CONTEXT
Health-related quality of life (HRQOL) parameters have been shown to be reliable and valid in patients with adult spinal deformity (ASD). Minimum clinically important difference (MCID) has become increasingly important to clinicians in evaluating patients with a threshold of improvement that is clinically relevant.PURPOSE
To calculate MCID and minimum detectable change (MDC) values of total scores of the Core Outcome Measures Index (COMI), Oswestry Disability Index (ODI), Physical Component Summary (PCS), Mental Component Summary (MCS) of the Short Form 36 (SF-36), and Scoliosis Research Society 22R (SRS-22R) in surgically and nonsurgically treated ASD patients who have completed an anchor question at pretreatment and 1-year follow-up.STUDY DESIGN/SETTING
Prospective cohort.PATIENT SAMPLE
Surgical and nonsurgical patients from a multicenter ASD database.OUTCOME MEASURES
Self-reported HRQOL measures (COMI, ODI, SF-36, SRS-22R, and anchor question).METHODS
A total of 185 surgical and 86 nonsurgical patients from a multicenter ASD database who completed pretreatment and 1-year follow-up HRQOL scales and the anchor question at the first year follow-up were included. The anchor question was used to determine MCID for each HRQOL measure. MCIDs were calculated by an anchor-based method using latent class analysis (LCA) and MDCs by a distribution-based method.RESULTS
All differences between means of baseline and first year postoperative total score measures for all scales demonstrated statistically significant improvements in the overall population as well as the surgically treated patients but not in the nonsurgical group. The calculated MDC and MCID values of HRQOL parameters in the entire study population were 1.34 and 2.62 for COMI, 10.65 and 14.31 for ODI, 6.09 and 7.33 for SF-36 PCS, 6.14 and 4.37 for SF-36 MCS, and 0.42 and 0.71 for SRS-22R. The calculated MCID values for surgical and non-surgical treatment groups were 2.76 versus 1.20 for COMI, 14.96 versus 2.45 for ODI, 7.83 versus 2.15 for SF-36 PCS, 5.14 versus 2.03 for SF-36 MCS, and 0.94 versus 0.11 for SRS-22R; the MDC values for surgical and nonsurgical treatment groups were 1.22 versus 1.51 for COMI, 10.27 versus 9.45 for ODI, 5.16 versus 6.77 for SF-36 PCS, 6.05 versus 5.67 for SF-36 MCS, and 0.38 versus 0.43 for SRS-22R.CONCLUSIONS
This study has demonstrated that MCID calculations for the HRQOL scales in ASD using LCA yield values comparable to other studies that had used different methodologies. The most important finding was the significantly different MCIDs for COMI, ODI, SF-36 PCS and SRS-22 in the surgically and nonsurgically treated cohorts. This finding suggests that a universal MCID value, inherent to a specific HRQOL for an entire cohort of ASD may not exist. Use of different MCIDs for surgical and nonsurgical patients may be warranted. 相似文献10.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516